FindTrial
Sign In

Quality of Life in lung cancer patient with brain metastasis.

Prospective assessment of the quality of life in patient diagnosed with carcinoma lung with brain metastasis receiving short course palliative whole brain radiotherapy .

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/01/003299
Enrollment
140
Registered
2013-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Histologically proven carcinoma lung radiological diagnosis of brain metastases.

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Histologically proven carcinoma lung with radiological diagnosis of brain metastases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To assess the quality of life of patient of lung carcinoma with brain metastases with EORTC QLQ 30 and EORTC BN20 module at the baseline, at 1 month, at 3 month, at 6 month after whole Brain Radiotherapy (WBRT)Timepoint: To assess the quality of life of patient of lung carcinoma with brain metastases with EORTC QLQ 30 and EORTC BN20 module at the baseline, at 1 month, at 3 month, at 6 month after whole Brain Radiotherapy (WBRT)—

Secondary

MeasureTime frame
To correlate RPA,GPA and other prognostic factors with quality of life indices .Timepoint: Baseline, at 1 month, at 3 month, at 6 monthly follow up after whole Brain Radiotherapy (WBRT)—

Countries

India

Contacts

Public ContactDR J P AGARWAL

TATA MEMORIAL HOSPITAL

agarwaljp@tmc.gov.in02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 10, 2026